| Question | Answer |
| Currently used in the treatment of diabetes and they act by binding to their G-protein coupled receptor to increase intracellular Ca activating insulin release. | |
| percentage of delta cells in the pancreas | |
| percentage of beta cells in the pancreas | |
| Blood glucose levels must be maintained at ___mg/ 100ml. | |
| Major targets of insulin include liver, _____ and _____ | |
| T/F: C peptide has no biological funtion. | |
| percentage of alpha cells in the pancreas | |
| The B subunit of the insulin receptor acts to bind and recognize insulin. | |
| In liver, glucose stimulates which enzyme? | |
| T/F: Glucose enters the cell via active transport. | |
| these cells of the pancreas make somatostatin | |
| T/F: Basal glucose levels in a diabetic patient are equivalent to non-diabetic patient. | |
| How much oral glucose is administered during a glucose tolerance test? (grams) | |
| Normal blood glucose levels are ___mg/ dl | |
| insulin dependent transporter | |
| persistent hyperglycemia causes perisistent _______. | |
| T/F: 98% of the pancreas has endocrine function. | |
| T/F: Hepatocytes contain GLUT4 transporters. | |
| T/F: Influx of glucose in a hepatocyte activates glucokinase which increase ATP levels, activating ATP dependent K channel. This causes a depolarization of the cell causing an incr | |
| These drugs act on the ATP dependent K channel to activate insulin secretion | |
| insulin deficiency causes a (an) _____ in plasma glucose | |
| T/F: An increase in sympathetic activity, increases production and synthesis of insulin. | |
| insulin independent diabetes | |